REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
01/31/2026
Back to search
Official data from USPTO
ALLES INSTITUTE FOR MEDICAL RESEARCH
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ALLES INSTITUTE FOR MEDICAL RESEARCH
ST13
US500000086853715Class
42
Filing
86853715
Registration
5134595
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
02/01/2026
Trademark type
Word
Nice classes
42
Filing date
12/18/2015
Registration date
01/31/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/05/2023
Last transaction
02/01/2026
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
12/01/2016
First use in commerce
12/01/2016
Drawing code
4
Owner type
99
Owner location
El Cerrito, CA
Examiner
GOODSAID, IRA
Law office
L10
Current location
TMEG LAW OFFICE 101
Holders and representatives
Holders
Alles Institute for Medical Research
Representatives
Matthew G. Minder Bryan Cave Leighton Paisner LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Medical research servicesconducting research into autoimmune diseases
Publications
History of USPTO decisions and trademark events.
29 publications found
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
06/05/2023
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
06/05/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/05/2023
E815
TEAS SECTION 8 & 15 RECEIVED
11/29/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
01/31/2022
CORV
REVIEW OF CORRESPONDENCE COMPLETE - POWER OF ATTORNEY ENTERED
02/24/2017
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
02/24/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
01/31/2017
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
12/29/2016
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
12/28/2016
SUPC
STATEMENT OF USE PROCESSING COMPLETE
12/28/2016
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
12/22/2016
IUAF
USE AMENDMENT FILED
12/01/2016
EISU
TEAS STATEMENT OF USE RECEIVED
12/01/2016
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
08/02/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/07/2016
PUBO
PUBLISHED FOR OPPOSITION
06/07/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/18/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
04/29/2016
ALIE
ASSIGNED TO LIE
04/21/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/07/2016
XAEC
EXAMINER'S AMENDMENT ENTERED
04/06/2016
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/06/2016
GNEA
EXAMINERS AMENDMENT E-MAILED
04/06/2016
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/06/2016
DOCK
ASSIGNED TO EXAMINER
04/06/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/29/2015
NWAP
NEW APPLICATION ENTERED
12/22/2015
Continuous trademark protection
Get notified about every new filing that threatens ALLES INSTITUTE FOR MEDICAL RESEARCH or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.